Announced Mon, 6 Jul · 15:17 IST
Board appoints auditors and authorizes growth exploration
Management Changes View source PDF
SAIPARENT · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.6%1-day move
₹620.55
prior close
₹610.35
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2-0.1——-3.6-4.8-4.3-5.0-5.4-8.5-10.1———
Up moveDown movePending
AI summary
Sai Parenterals board met on 6 July 2026 and approved three auditor appointments: M/s. Aakanksha Dubey & Co. as Secretarial Auditors for 5 years (FY 2026-27 to 2030-31), M/s. NSVR & Associates LLP as Internal Auditors for FY 2026-27, and M/s. Sai Krishna & Associates as Cost Auditors for FY 2026-27. The board also authorised CMD Anil Kumar Karusala to identify and explore organic and inorganic growth opportunities in existing or strategic areas.
Likely market impact
Routine governance updates; auditor appointments strengthen compliance framework. Growth authorisation signals potential expansion plans ahead.